Not applicableStudy completedNCT01059734What this trial is testingS9031-S9126-S9333-S9500-B Biomarker Expression in Patients With Acute Myeloid LeukemiaWho this might be right forLeukemia SWOG Cancer Research Network 357
Testing effectiveness (Phase 2)UnknownNCT00003681What this trial is testingAmifostine With or Without Epoetin Alfa in Treating Patients With Myelodysplastic SyndromeWho this might be right forAnemiaMyelodysplastic Syndromes European Organisation for Research and Treatment of Cancer - EORTC 50
Testing effectiveness (Phase 2)Study completedNCT00407966What this trial is testingAlvocidib, Cytarabine, and Mitoxantrone in Treating Patients With Newly Diagnosed Acute Myeloid LeukemiaWho this might be right forAdult Acute Basophilic LeukemiaAdult Acute Eosinophilic LeukemiaAdult Acute Megakaryoblastic Leukemia (M7)+14 more National Cancer Institute (NCI) 45
Not applicableStudy completedNCT00897767What this trial is testingCollecting Tissue Samples From Patients With Leukemia or Other Blood Disorders Planning to Enroll in an ECOG Leukemia Treatment Clinical TrialWho this might be right forLeukemiaLymphoma Eastern Cooperative Oncology Group 1,873
Early research (Phase 1)Study completedNCT00028899What this trial is testingMonoclonal Antibody Plus Chemotherapy in Treating Young Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic SyndromesWho this might be right forLeukemiaMyelodysplastic Syndromes Children's Oncology Group 47
Large-scale testing (Phase 3)Looking for participantsNCT07202052What this trial is testingRole of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Platform Trial (RATIONAL-PT)Who this might be right forMyelomaNon-Hodgkin's LymphomaLeukemia Monash University 900
Testing effectiveness (Phase 2)Looking for participantsNCT06506643What this trial is testingSafety and Efficacy of KLS-1 Monotherapy in Malignant NeoplasmsWho this might be right forCLLSolid Tumor, Adult Vector Vitale LLC 36
Large-scale testing (Phase 3)Looking for participantsNCT07648264What this trial is testingSingle-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting TherapiesWho this might be right forSecondary Immune Deficiency CSL Behring 63
Testing effectiveness (Phase 2)Study completedNCT00084916What this trial is testingCCI-779 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes, or Chronic Myelogenous Leukemia in Blastic PhaseWho this might be right forAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Inv(16)(p13;q22)Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)+12 more National Cancer Institute (NCI) 74
Early research (Phase 1)Study completedNCT00502385What this trial is testingPhase I AZD2171 in Patients With Relapsed or Refractory AML and Elderly Patients With DeNovo or Secondary AMLWho this might be right forLeukaemiaMyelocyticAcute AstraZeneca 54
Testing effectiveness (Phase 2)Study completedNCT00782379What this trial is testingCombination Chemotherapy, Donor Stem Cell Transplant, Tacrolimus, Mycophenolate Mofetil, and Cyclophosphamide in Treating Patients With Hematologic CancerWho this might be right forLeukemiaLymphomaMyelodysplastic Syndromes Northside Hospital, Inc. 20
Early research (Phase 1)UnknownNCT00769613What this trial is testingEmergency Use of Donor Lymphocytes in Treating Patients Who Have Undergone Donor Stem Cell Transplant and Have Cytomegalovirus InfectionsWho this might be right forCancer Milton S. Hershey Medical Center 20
Testing effectiveness (Phase 2)Looking for participantsNCT06928662What this trial is testingChemotherapy (Decitabine in Combination With FLAG-Ida) and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treatment of Adults With Myeloid Malignancies at High Risk of RelapseWho this might be right forAcute Myeloid LeukemiaAcute Undifferentiated LeukemiaMixed Phenotype Acute Leukemia+11 more Fred Hutchinson Cancer Center 36
Very early researchStudy completedNCT00424242What this trial is testingPemetrexed Disodium in the Cerebrospinal Fluid of Patients With Leptomeningeal MetastasesWho this might be right forBrain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+8 more Northwestern University 15
Early research (Phase 1)Study completedNCT00042900What this trial is testingPyroxamide in Treating Patients With Advanced CancerWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+5 more Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT02743611What this trial is testingSafety & Activity of Controllable PRAME-TCR Therapy in Previously Treated AML/MDS or Metastatic Uveal MelanomaWho this might be right forAcute Myeloid LeukemiaMyelodysplastic SyndromeUveal Melanoma Bellicum Pharmaceuticals 4
Testing effectiveness (Phase 2)Study completedNCT00531232What this trial is testingA Dose Confirmation Study of Oral Clofarabine for Adult Patients Previously Treated for Myelodysplastic Syndromes (MDS)Who this might be right forMyelodysplastic SyndromesSecondary Acute Myeloid Leukemia (AML) Genzyme, a Sanofi Company 38
Early research (Phase 1)Active Not RecruitingNCT02890329What this trial is testingIpilimumab and Decitabine in Treating Patients With Relapsed or Refractory Myelodysplastic Syndrome or Acute Myeloid LeukemiaWho this might be right forPreviously Treated Myelodysplastic SyndromeRecurrent Acute Myeloid LeukemiaRecurrent Acute Myeloid Leukemia, Myelodysplasia-Related+5 more National Cancer Institute (NCI) 54
Large-scale testing (Phase 3)Ended earlyNCT01203228What this trial is testingDose-reduced Versus Standard Conditioning in MDS/sAMLWho this might be right forMyelodysplastic SyndromesSecondary Acute Myeloid Leukemia European Society for Blood and Marrow Transplantation 129
Testing effectiveness (Phase 2)Active Not RecruitingNCT04284787What this trial is testingBLAST MRD AML-2: BLockade of PD-1 Added to Standard Therapy to Target Measurable Residual Disease in Acute Myeloid Leukemia 2- A Randomized Phase 2 Study of Anti-PD-1 Pembrolizumab in Combination With Azacitidine and Venetoclax as Frontline Therapy in Unfit Patients With Acute Myeloid LeukemiaWho this might be right forAcute Myeloid LeukemiaAcute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeAcute Myeloid Leukemia Post Cytotoxic Therapy+1 more National Cancer Institute (NCI)